As of February 26, 2024, Kerrisdale Capital has reiterated to Benzinga their position on Altimmune (ALT) – they remain bearish on the stock. This suggests that Kerrisdale Capital is sticking to their belief that Altimmune’s performance in the market will not meet expectations, as they continue to hold a short position on the company.
ALT Stock Surges 29.08% on February 26, 2024: Potential for Significant Gains in Stock Market
On February 26, 2024, ALT stock had an impressive performance as it traded near the top of its 52-week range and above its 200-day simple moving average. The price of ALT shares increased by $2.68 since the market last closed, representing a significant 29.08% rise. The stock opened at $10.42 on that day, which was $1.22 higher than its previous close, indicating positive momentum for ALT stock. Investors were likely encouraged by the price momentum of ALT stock as it continued to climb higher throughout the trading session. The 29.08% increase in share price reflected growing confidence in the company’s performance and future prospects. ALT’s strong performance on February 26, 2024, demonstrated the potential for significant gains in the stock market. Overall, the positive price momentum and significant increase in share price highlighted the potential for growth and success in ALT stock. Investors will continue to monitor the company’s performance and market trends to make informed decisions about their investment strategies.
ALT Stock Performance Analysis: Mixed Results on February 26, 2024
On February 26, 2024, ALT stock experienced mixed performances based on the data provided by CNN Money. The company’s total revenue for the past year was reported at -$68.00K, indicating a significant decrease of 101.54% compared to the previous year. However, in the third quarter of the same year, the total revenue surged to $362.00K, marking an impressive increase of 5933.33% since the last quarter.
Similarly, ALT’s net income showed contrasting trends over the same period. The net income for the past year was reported at -$84.71M, showing a slight increase of 12.75% compared to the previous year. However, in the third quarter, the net income decreased to -$20.67M, representing a decline of 28.7% since the last quarter.
The earnings per share (EPS) for ALT stock also exhibited diverging patterns. The EPS for the past year was reported at -$1.81, indicating an increase of 23.24% compared to the previous year. However, in the third quarter, the EPS decreased to -$0.39, marking a decline of 21.65% since the last quarter.
Overall, ALT stock’s performance on February 26, 2024, reflected a mix of positive and negative trends in terms of total revenue, net income, and earnings per share. Investors and analysts will likely closely monitor the company’s financial results in the upcoming quarters to assess its future growth prospects and potential investment opportunities.
